Abstract
Modern medicine provides almost infinite diagnostic and therapeutic possibilities if compared to the past. As a result, patients undergo a multiplication of tests and therapies, which in turn may trigger further tests, often based on physicians’ attitudes or beliefs, which are not always evidence-based. The Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) adhered to the Choosing Wisely Campaign to promote an informed, evidence-based approach to gastroenterological problems. The aim of this article is to report the five recommendations of the AIGO Choosing Wisely Campaign, and the process used to develop them. The AIGO members’ suggestions regarding inappropriate practices/interventions were collected. One hundred and twenty-one items were identified. Among these, five items were selected and five recommendations were developed. The five recommendations developed were: (1) Do not request a fecal occult blood test outside the colorectal cancer screening programme; (2) Do not repeat surveillance colonoscopy for polyps, after a quality colonoscopy, before the interval suggested by the gastroenterologist on the colonoscopy report, or based on the polyp histology report; (3) Do not repeat esophagogastroduodenoscopy in patients with reflux symptoms, with or without hiatal hernia, in the absence of different symptoms or alarm symptoms; (4) Do not repeat abdominal ultrasound in asymptomatic patients with small hepatic haemangiomas (diameter < 3 cm) once the diagnosis has been established conclusively; (5) Do not routinely prescribe proton pump inhibitors within the context of steroid use or long-term in patients with functional dyspepsia. AIGO adhered to the Choosing Wisely Campaign and developed five recommendations. Further studies are needed to assess the impact of these recommendations in clinical practice with regards to clinical outcome and cost-effectiveness.
Similar content being viewed by others
References
O’Sullivan JW, Muntinga T, Grigg S, Ioannidis JPA (2018) Prevalence and outcomes of incidental imaging findings: umbrella review. BMJ 18(361):k2387
Deyo RA (2002) Cascade effects of medical technology. Annu Rev Public Health 23:23–44
Wolfson D, Santa J, Slass L (2014) Engaging physicians and consumers in conversations about treatment overuse and waste: a short history of the choosing wisely campaign. Acad Med 89(7):990–995
Montano N, Costantino G, Casazza G et al (2016) The Italian Society of Internal Medicine choosing wisely campaign. Intern Emerg Med 11(8):1125–1130
Hillis CM, Schimmer AD, Couban S et al (2015) The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments. Ann Hematol 94(4):541–545
Ho T, Dukhovny D, Zupancic JA et al (2015) Choosing wisely in newborn medicine: five opportunities to increase value. Pediatrics 136(2):e482–e489
Hahn C, Kavanagh B, Bhatnagar A et al (2014) Choosing wisely: the American Society for Radiation Oncology’s top 5 list. Pract. Radiat Oncol 4(6):349–355
Bulger J, Nickel W, Messler J et al (2013) Choosing wisely in adult hospital medicine: five opportunities for improved healthcare value. J Hosp Med 8(9):486–492
Loder E, Weizenbaum E, Frishberg B et al (2013) Choosing wisely in headache medicine: the American Headache Society’s list of five things physicians and patients should question. Headache. 53(10):1651–1659
Hicks LK, Bering H, Carson KR et al (2013) The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood 122(24):3879–3883
Mitera G, Earle C, Latosinsky S et al (2015) Choosing Wisely Canada cancer list: ten low-value or harmful practices that should be avoided in cancer care. J Oncol Pract. 11(3):e296–e303
Wiener RS, Ouellette DR, Diamond E et al (2014) An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine. Chest 145(6):1383–1391
Nguyen GC, Boland K, Afif W et al (2017) Modified Delphi process for the development of choosing wisely for inflammatory bowel disease. Inflamm Bowel Dis 23(6):858–865
Winawer S, Fletcher R, Rex D et al (2003) Gastrointestinal consortium panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124(2):544–560
Knudsen AB, Zauber AG, Rutter CM et al (2016) Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. JAMA 315(23):2595–2609
Fisher DA, Judd L, Sanford NS (2005) Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol 100(11):2526–2530
Powell AA, Saini SD, Breitenstein MK et al (2015) Rates and correlates of potentially inappropriate colorectal cancer screening in the veterans health administration. J Gen Intern Med 30(6):732–741
Friedman A, Chan A, Chin LC et al (2010) Use and abuse of faecal occult blood tests in an acute hospital inpatient setting. Intern Med J 40(2):107–111
Narula N, Ulic D, Al-Dabbagh R et al (2014) Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review. Can J Gastroenterol Hepatol. 28(8):421–426
Rao SK, Schilling TF, Sequist TD (2009) Challenges in the management of positive fecal occult blood tests. J Gen Intern Med 24(3):356–360
Mosadeghi S, Ren H, Catungal J et al (2016) Utilization of fecal occult blood test in the acute hospital setting and its impact on clinical management and outcomes. J Postgrad Med 62(2):91–95
van Rijn AF, Stroobants AK, Deutekom M et al (2012) Inappropriate use of the faecal occult blood test in a University Hospital in the Netherlands. Eur J Gastroenterol Hepatol 24(11):1266–1269
Winawer SJ, Zauber AG, Ho MN et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N Engl J Med 329(27):1977–1981
Cottet V, Jooste V, Fournel I et al (2012) Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut 61(8):1180–1186
Brenner H, Chang-Claude J, Rickert A et al (2012) Risk of colorectal cancer after detection and removal of adenomas at colonoscopy: population-based case-control study. J Clin Oncol 30(24):2969–2976
Cairns SR, Scholefield JH, Steele RJ et al (2010) British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 59(5):666–689
Lieberman DA, Rex DK, Winawer SJ et al (2012) United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143(3):844–857
Hassan C, Quintero E, Dumonceau JM et al (2013) European Society of Gastrointestinal Endoscopy. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 45(10):842–851
Radaelli F, Paggi S, Bortoli A et al (2012) Italian Association of Hospital Gastroenterologists (AIGO). Overutilization of post-polypectomy surveillance colonoscopy in clinical practice: a prospective, multicentre study. Dig Liver Dis 44(9):748–753
Van Heijningen EM, Lansdorp-Vogelaar I, Steyerberg EW et al (2015) Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study. Gut 64(10):1584–1592
Anderson JC, Baron JA, Ahnen DJ et al (2017) Factors associated with shorter colonoscopy surveillance intervals for patients with low-risk colorectal adenomas and effects on outcome. Gastroenterology 152(8):1933–1943
Van Hees F, Zauber AG, Klabunde CN et al (2014) The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study. JAMA Intern Med. 174(10):1568–1576
Whitlock EP, Lin JS, Liles E et al (2008) Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Int Med 149:638–658
Warren JL, Klabunde CN, Mariotto AB et al (2009) Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 150(849–57):W152
DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100:190–200
El-Serag HB, Sweet S, Winchester CC et al (2014) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63:871–880
Kahrilas PJ, Shaheen NJ, Vaezi MF et al (2008) American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 135:1383–1391
Vakil N, van Zanten SV, Kahrilas P et al (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900–1920
Katz PO, Gerson LB, Vela MF (2013) Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 108:308–328
Shaheen NJ, Weinberg DS, Denberg TD et al (2012) Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med 157:808–816
Vaira D, Gatta L, Ricci C et al (2011) Gastroesophageal reflux disease and Barrett’s esophagus. Intern Emerg Med 6(4):299–306
Fock KM, Talley N, Hunt R et al (2004) Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol 19:357–367
NICE Clinical guideline (2014) Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. nice.org.uk/guidance/cg184
Takubo K, Honma N, Aryal G et al (2009) Is there a set of histologic changes that are invariably reflux associated? Arch Pathol Lab Med 129:159–163
Horta G, Lopez M, Dotte A et al (2015) Benign focal liver lesions detected by computed tomography: review of 1,184 examinations. Rev Med Chil 143:197–202
Bahirwani R, Reddy KR (2008) Review article: the evaluation of solitary liver masses. Aliment Pharmacol Ther 28:953–965
Gandolfi L, Leo P, Solmi L et al (1991) Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut 32(6):677–680
Mungovan JA, Cronan JJ, Vacarro J (1994) Hepatic cavernous hemangiomas: lack of enlargement over time. Radiology 191(1):111–113
Okano H, Shiraki K, Inoue H et al (2001) Natural course of cavernous hepatic hemangioma. Oncol Rep 8(2):411–414
Gibney RG, Hendin AP, Cooperberg PL (1987) Sonographically detected hepatic hemangiomas: absence of change over time. AJR Am J Roentgenol 149(5):953–957
Hasan HY, Hinshaw JL, Borman EJ et al (2014) Assessing normal growth of hepatic hemangiomas during long-term follow-up. JAMA Surg. 149(12):1266–1271
Herman P, Costa ML, Machado MA et al (2005) Management of hepatic hemangiomas: a 14-year experience. J Gastrointest Surg 9:853–859
Clinical EASL (2016) Practice Guidelines on the management of benign liver tumours. European Association for the Study of the Liver (EASL). J Hepatol 65(2):386–398
Scarpignato C, Gatta L, Zullo A et al (2016) Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression. BMC Med 14:179
Munson JC, Wahl PM, Daniel G et al (2012) Factors associated with the initiation of proton pump inhibitors in corticosteroid users. Pharmacoepidemiol Drug Saf 21:366–374
Heidelbaugh JJ, Kim AH, Chang R et al (2012) Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol 5:219–232
Savarino V, Dulbecco P, De Bortoli N et al (2017) The appropriate use of proton pump inhibitors: need for a reappraisal. Eur J Internal Med 37:19–24
Stanghellini V, Chan FKL, Hasler WL et al (2016) Gastroduodenal disorders. Gastroenterology 150:1380–1392
Moayyedi P, Delaney BC, Vakil N et al (2004) The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 127:1329–1337
Moayyedi P, Lacy BE, Andrews CN et al (2017) ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol 112:988–1013
Levinson W, Huynh T (2014) Engaging physicians and patients in conversations about unnecessary tests and procedures: choosing wisely Canada. CMAJ 186(5):325–326
Buscarini E, Conte D, Cannizzaro R et al (2014) White paper of Italian gastroenterology: delivery of services for digestive diseases in Italy: weaknesses and strengths. Dig Liver Dis. 46(7):579–589
Asch DA, Nicholson S, Srinivas S et al (2009) Evaluating obstetrical residency programs using patient outcomes. JAMA 302:1277–1283
Cardone F, Cheung D, Han A et al (2017) Choosing Wisely Canada Students and trainees advocating for resource stewardship (STARS) campaign: a descriptive evaluation. CMAJ Open. 5(4):E864–E871
Elli L, Tenca A, Soncini M et al (2013) Defensive medicine practices among gastroenterologists in Lombardy: between lawsuits and the economic crisis. Dig Liver Dis. 45(6):469–473
Hiyama T, Yoshihara M, Tanaka S et al (2006) Defensive medicine practices among gastroenterologists in Japan. World J Gastroenterol 12:7671–7675
Kessler DP, Summerton N, Graham JR (2006) Effects of the medical liability system in Australia, the UK, and the USA. Lancet 368:240–246
Institute of Medicine (US) (2010) Roundtable on Evidence-Based Medicine. In: Yong PL, Saunders RS, Olsen LA (eds) The healthcare imperative: lowering costs and improving outcomes: workshop series summary. National Academies Press, Washington (DC)
Dzau VJ, Kirch DG, Nasca TJ (2018) To care is human—collectively confronting the clinician-burnout crisis. N Engl J Med 378(4):312–314
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
None.
Rights and permissions
About this article
Cite this article
Stasi, E., Michielan, A., Morreale, G.C. et al. Five common errors to avoid in clinical practice: the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) Choosing Wisely Campaign. Intern Emerg Med 14, 301–308 (2019). https://doi.org/10.1007/s11739-018-1992-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-018-1992-x